Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
March 12, 2020
IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities
March 3, 2020
Akouos Closes $105 Million Series B Financing
February 28, 2020
RareCyte Announces the First Blood-to-Result PD-L1 Circulating Tumor Cell Assay
February 26, 2020
Nouscom Strengthens Its Management Team
February 13, 2020
Homology Medicines Presents New Data Characterizing AAVHSCs as Potential Gene Therapies for Nervous System Disorders
January 30, 2020
Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) with a TP53 Mutation
January 29, 2020
Cabaletta Bio: FDA Grants DSG3-CAART Orphan Drug Designation for the Treatment of Pemphigus Vulgaris
January 21, 2020
Kinestral Technologies Showcases Modern Window Functionalities for the Connected Smart Home at IBS/KBIS 2020
January 15, 2020
Astellas Completes Acquisition of Audentes Therapeutics
January 13, 2020
Pear Therapeutics Announces Collaboration with Apricity Health to Advance Prescription Digital Therapeutics to be Prescribed in Combination with Immuno-oncology Therapy
« Previous Page
1
…
11
12
13
14
Next Page »